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  Abstract: 
 The risks of late effects from galactic cosmic rays (GCR) and solar particle events (SPE) are 
potentially a limitation to long-term space travel. The late effects of highest concern have significant 
lethality including cancer, effects to the central nervous system (CNS), and circulatory diseases (CD). For 
cancer and CD the use of age and gender specific models with uncertainty assessments based on human 
epidemiology data for low LET radiation combined with relative biological effectiveness factors (RBEs) 
and dose- and dose-rate reduction effectiveness factors (DDREF) to extrapolate these results to space 
radiation exposures is considered the current “state-of-the-art”. The revised NASA Space Risk Model 
(NSRM-2014) is based on recent radio-epidemiology data for cancer and CD, however a key feature of 
the NSRM-2014 is the formulation of  particle fluence and track structure based radiation quality factors 
for solid cancer and leukemia risk estimates, which are distinct from the ICRP quality factors, and shown 
to lead to smaller uncertainties in risk estimates. Many persons exposed to radiation on earth  as well as 
astronauts are life-time never-smokers, which is estimated to significantly modify radiation cancer and 
CD risk estimates. A key feature of the NASA radiation protection model is the classification of radiation 
workers by smoking history in setting dose limits.   Possible qualitative differences between GCR and 
low LET radiation increase uncertainties and are not included in previous risk estimates.  Two important 
qualitative differences are emerging from research studies. The first is the increased lethality of tumors 
observed in animal models compared to low LET radiation or background tumors. The second are Non-
Targeted Effects (NTE), which include bystander effects and genomic instability, which has been 
observed in cell and animal models of cancer risks. NTE’s could lead to significant changes in RBE and 
DDREF estimates for GCR particles, and the potential effectiveness of radiation mitigator’s. The NSRM-
2014 approaches to model radiation quality dependent lethality and NTE’s will be described.  
 CNS effects include both early changes that may occur during long space missions and late 
effects such as Alzheimer’s disease (AD). AD effects 50% of the population above age 80-yr,  is a 
degenerative disease that worsens with time after initial onset leading to death, and has no known cure. 
AD is difficult to detect at early stages and the small number of low LET epidemiology studies 
undertaken have not identified an association with low dose radiation. However experimental studies in 
mice suggest GCR may lead to early onset AD. We discuss modeling approaches to consider mechanisms 
whereby radiation would lead to earlier onset of occurrence of AD.  Biomarkers of AD include amyloid 
beta (A) plaques, and neurofibrillary tangles (NFT) made up of aggregates of the hyperphosphorylated 
form of the micro-tubule associated, tau protein. Related markers include synaptic degeneration, dentritic 
spine loss, and neuronal cell loss through apoptosis. Radiation may affect these processes by causing 
oxidative stress, aberrant signaling following DNA damage, and chronic neuroinflammation. Cell types to  
be considered in multi-scale models are neurons, astrocytes, and microglia. We developed biochemical 
and cell kinetics models of DNA damage signaling related to glycogen synthase kinase-3 (GSK3) and 
neuroinflammation, and considered multi-scale modeling approaches to develop computer simulations of  
cell interactions and their relationships to A plaques and NFTs.  Comparison of model results to 
experimental data for the age specific development of A plaques in transgenic mice will be discussed. 
https://ntrs.nasa.gov/search.jsp?R=20140000698 2019-08-29T15:24:44+00:00Z
